Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2021

 

Upgrades

According to Keefe, Bruyette & Woods, the prior rating for Old National Bancorp ONB was changed from Market Perform to Outperform. Old National Bancorp earned $0.43 in the third quarter, compared to $0.46 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.28 and a 52-week-low of $15.53. Old National Bancorp closed at $17.31 at the end of the last trading period.

According to Keefe, Bruyette & Woods, the prior rating for First Midwest Bancorp Inc FMBI was changed from Market Perform to Outperform. First Midwest Bancorp earned $0.46 in the third quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $24.28 and a 52-week-low of $15.05. At the end of the last trading period, First Midwest Bancorp closed at $19.47.

According to Fox Advisors, the prior rating for Lyft Inc LYFT was changed from Equal-Weight to Overweight. In the third quarter, Lyft showed an EPS of $0.05, compared to $0.89 from the year-ago quarter. The current stock performance of Lyft shows a 52-week-high of $68.28 and a 52-week-low of $36.25. Moreover, at the end of the last trading period, the closing price was at $38.07.

Morgan Stanley upgraded the previous rating for Cerner Corp CERN from Underweight to Equal-Weight. For the third quarter, Cerner had an EPS of $0.86, compared to year-ago quarter EPS of $0.72. At the moment, the stock has a 52-week-high of $92.34 and a 52-week-low of $67.96. Cerner closed at $89.77 at the end of the last trading period.

For GFL Environmental Inc GFL, TD Securities upgraded the previous rating of Hold to Buy. In the third quarter, GFL Environmental showed an EPS of $0.22, compared to $0.13 from the year-ago quarter. The stock has a 52-week-high of $43.71 and a 52-week-low of $26.50. At the end of the last trading period, GFL Environmental closed at $35.39.

Scotiabank upgraded the previous rating for Ternium SA TX from Sector Perform to Sector Outperform. Ternium earned $6.12 in the third quarter, compared to $0.74 in the year-ago quarter. The stock has a 52-week-high of $56.86 and a 52-week-low of $26.41. At the end of the last trading period, Ternium closed at $42.39.

According to Deutsche Bank, the prior rating for Pactiv Evergreen Inc PTVE was changed from Hold to Buy. In the third quarter, Pactiv Evergreen showed an EPS of $0.01, compared to $0.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.87 and a 52-week-low of $10.57. Pactiv Evergreen closed at $12.47 at the end of the last trading period.

For Dover Corp DOV, Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. Dover earned $1.98 in the third quarter, compared to $1.60 in the year-ago quarter. The current stock performance of Dover shows a 52-week-high of $178.32 and a 52-week-low of $115.88. Moreover, at the end of the last trading period, the closing price was at $170.29.

According to HC Wainwright & Co., the prior rating for Genfit SA GNFT was changed from Neutral to Buy. NoneAt the moment, the stock has a 52-week-high of $7.19 and a 52-week-low of $3.01. Genfit closed at $5.09 at the end of the last trading period.

According to Needham, the prior rating for Teradata Corp TDC was changed from Hold to Buy. For the third quarter, Teradata had an EPS of $0.43, compared to year-ago quarter EPS of $0.43. The current stock performance of Teradata shows a 52-week-high of $59.58 and a 52-week-low of $21.83. Moreover, at the end of the last trading period, the closing price was at $42.76.

According to JP Morgan, the prior rating for Federal Realty Investment Trust FRT was changed from Neutral to Overweight. For the third quarter, Federal Realty Investment had an EPS of $1.51, compared to year-ago quarter EPS of $1.12. The stock has a 52-week-high of $135.56 and a 52-week-low of $81.85. At the end of the last trading period, Federal Realty Investment closed at $129.52.

For Healthpeak Properties Inc PEAK, JP Morgan upgraded the previous rating of Neutral to Overweight. In the third quarter, Healthpeak Properties showed an EPS of $0.40, compared to $0.40 from the year-ago quarter. The current stock performance of Healthpeak Properties shows a 52-week-high of $37.69 and a 52-week-low of $28.14. Moreover, at the end of the last trading period, the closing price was at $34.92.

For Public Storage PSA, JP Morgan upgraded the previous rating of Neutral to Overweight. For the third quarter, Public Storage had an EPS of $3.42, compared to year-ago quarter EPS of $2.63. At the moment, the stock has a 52-week-high of $368.97 and a 52-week-low of $212.22. Public Storage closed at $361.74 at the end of the last trading period.

For Rexford Industrial Realty Inc REXR, JP Morgan upgraded the previous rating of Neutral to Overweight. In the third quarter, Rexford Industrial Realty showed an EPS of $0.43, compared to $0.33 from the year-ago quarter. The current stock performance of Rexford Industrial Realty shows a 52-week-high of $77.24 and a 52-week-low of $45.90. Moreover, at the end of the last trading period, the closing price was at $75.84.

JP Morgan upgraded the previous rating for Realogy Holdings Corp RLGY from Neutral to Overweight. Realogy Holdings earned $0.99 in the third quarter, compared to $1.38 in the year-ago quarter. The current stock performance of Realogy Holdings shows a 52-week-high of $21.03 and a 52-week-low of $12.79. Moreover, at the end of the last trading period, the closing price was at $15.89.

According to Mizuho, the prior rating for Anthem Inc ANTM was changed from Neutral to Buy. Anthem earned $6.79 in the third quarter, compared to $4.20 in the year-ago quarter. At the moment, the stock has a 52-week-high of $451.71 and a 52-week-low of $286.04. Anthem closed at $445.10 at the end of the last trading period.

According to Jefferies, the prior rating for Boston Beer Co Inc SAM was changed from Underperform to Hold. In the third quarter, Boston Beer Co showed an EPS of $2.97, compared to $6.51 from the year-ago quarter. The current stock performance of Boston Beer Co shows a 52-week-high of $1349.98 and a 52-week-low of $435.12. Moreover, at the end of the last trading period, the closing price was at $531.80.

Barclays upgraded the previous rating for AT&T Inc T from Equal-Weight to Overweight. AT&T earned $0.87 in the third quarter, compared to $0.76 in the year-ago quarter. The current stock performance of AT&T shows a 52-week-high of $33.88 and a 52-week-low of $22.02. Moreover, at the end of the last trading period, the closing price was at $23.78.

For Limelight Networks Inc LLNW, Raymond James upgraded the previous rating of Market Perform to Strong Buy. For the third quarter, Limelight Networks had an EPS of $0.01, compared to year-ago quarter EPS of $0.01. The current stock performance of Limelight Networks shows a 52-week-high of $5.61 and a 52-week-low of $2.30. Moreover, at the end of the last trading period, the closing price was at $3.24.

See all analyst ratings upgrades.

Downgrades

For Sociedad Quimica Y Minera De Chile SA SQM, B of A Securities downgraded the previous rating of Neutral to Underperform. For the third quarter, Sociedad Quimica Y Minera had an EPS of $0.37, compared to year-ago quarter EPS of $0.01. The current stock performance of Sociedad Quimica Y Minera shows a 52-week-high of $71.50 and a 52-week-low of $40.53. Moreover, at the end of the last trading period, the closing price was at $55.91.

For Novo Nordisk A/S NVO, JP Morgan downgraded the previous rating of Overweight to Neutral. For the third quarter, Novo Nordisk had an EPS of $0.84, compared to year-ago quarter EPS of $0.69. The current stock performance of Novo Nordisk shows a 52-week-high of $117.35 and a 52-week-low of $66.59. Moreover, at the end of the last trading period, the closing price was at $107.45.

For Bottomline Technologies Inc EPAY, Craig-Hallum downgraded the previous rating of Buy to Hold. In the first quarter, Bottomline Technologies showed an EPS of $0.22, compared to $0.31 from the year-ago quarter. The stock has a 52-week-high of $56.40 and a 52-week-low of $36.05. At the end of the last trading period, Bottomline Technologies closed at $56.13.

For Itron Inc ITRI, Argus Research downgraded the previous rating of Buy to Hold. In the third quarter, Itron showed an EPS of $0.21, compared to $0.61 from the year-ago quarter. The current stock performance of Itron shows a 52-week-high of $122.31 and a 52-week-low of $60.07. Moreover, at the end of the last trading period, the closing price was at $65.57.

Citigroup downgraded the previous rating for Bottomline Technologies Inc EPAY from Buy to Neutral. For the first quarter, Bottomline Technologies had an EPS of $0.22, compared to year-ago quarter EPS of $0.31. The current stock performance of Bottomline Technologies shows a 52-week-high of $56.40 and a 52-week-low of $36.05. Moreover, at the end of the last trading period, the closing price was at $56.13.

Piper Sandler downgraded the previous rating for Canopy Growth Corp CGC from Neutral to Underweight. For the second quarter, Canopy Gwth had an EPS of $0.02, compared to year-ago quarter EPS of $0.22. The current stock performance of Canopy Gwth shows a 52-week-high of $56.50 and a 52-week-low of $8.69. Moreover, at the end of the last trading period, the closing price was at $9.59.

Goldman Sachs downgraded the previous rating for BrightView Holdings Inc BV from Buy to Neutral. BrightView Holdings earned $0.38 in the fourth quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.17 and a 52-week-low of $13.21. BrightView Holdings closed at $14.47 at the end of the last trading period.

According to JP Morgan, the prior rating for Welltower Inc WELL was changed from Overweight to Neutral. Welltower earned $0.80 in the third quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $89.80 and a 52-week-low of $59.38. At the end of the last trading period, Welltower closed at $83.20.

JP Morgan downgraded the previous rating for Extra Space Storage Inc EXR from Overweight to Neutral. In the third quarter, Extra Space Storage showed an EPS of $1.85, compared to $1.31 from the year-ago quarter. The current stock performance of Extra Space Storage shows a 52-week-high of $217.73 and a 52-week-low of $106.56. Moreover, at the end of the last trading period, the closing price was at $215.15.

JP Morgan downgraded the previous rating for Regency Centers Corp REG from Overweight to Neutral. Regency Centers earned $1.12 in the third quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $78.06 and a 52-week-low of $43.49. At the end of the last trading period, Regency Centers closed at $71.55.

According to Jefferies, the prior rating for Hayward Holdings Inc HAYW was changed from Buy to Hold. The current stock performance of Hayward Holdings shows a 52-week-high of $28.65 and a 52-week-low of $15.61. Moreover, at the end of the last trading period, the closing price was at $24.27.

According to Raymond James, the prior rating for Bottomline Technologies Inc EPAY was changed from Outperform to Market Perform. In the first quarter, Bottomline Technologies showed an EPS of $0.22, compared to $0.31 from the year-ago quarter. The current stock performance of Bottomline Technologies shows a 52-week-high of $56.40 and a 52-week-low of $36.05. Moreover, at the end of the last trading period, the closing price was at $56.13.

According to Keybanc, the prior rating for Sunrun Inc RUN was changed from Overweight to Sector Weight. Sunrun earned $0.11 in the third quarter, compared to $0.28 in the year-ago quarter. The current stock performance of Sunrun shows a 52-week-high of $100.93 and a 52-week-low of $32.03. Moreover, at the end of the last trading period, the closing price was at $34.23.

See all analyst ratings downgrades.

Initiations

Maxim Group initiated coverage on Ayala Pharmaceuticals Inc AYLA with a Buy rating. The price target for Ayala Pharmaceuticals is set to $22.00. Ayala Pharmaceuticals earned $0.68 in the third quarter, compared to $0.59 in the year-ago quarter. The stock has a 52-week-high of $28.68 and a 52-week-low of $7.74. At the end of the last trading period, Ayala Pharmaceuticals closed at $9.03.

With a Equal-Weight rating, Stephens & Co. initiated coverage on Southside Bancshares Inc SBSI. The price target seems to have been set at $45.00 for Southside Bancshares. For the third quarter, Southside Bancshares had an EPS of $0.90, compared to year-ago quarter EPS of $0.82. The stock has a 52-week-high of $45.36 and a 52-week-low of $30.21. At the end of the last trading period, Southside Bancshares closed at $40.80.

For Lucid Group Inc LCID, Guggenheim initiated coverage, by setting the current rating at Neutral. The current stock performance of Lucid Gr shows a 52-week-high of $42.50 and a 52-week-low of $36.35. Moreover, at the end of the last trading period, the closing price was at $40.01.

With a Buy rating, Citigroup initiated coverage on SoFi Technologies Inc SOFI. The price target seems to have been set at $20.00 for SoFi Technologies. In the third quarter, SoFi Technologies showed an EPS of $0.05, compared to $0.70 from the year-ago quarter. At the moment, the stock has a 52-week-high of $24.95 and a 52-week-low of $13.56. SoFi Technologies closed at $14.65 at the end of the last trading period.

With a Speculative Buy rating, Benchmark initiated coverage on BioTelemetry Inc BEAT. The price target seems to have been set at $9.00 for BioTelemetry. BioTelemetry earned $0.32 in the third quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $73.10 and a 52-week-low of $2.80. BioTelemetry closed at $2.93 at the end of the last trading period.

For Tesla Inc TSLA, Guggenheim initiated coverage, by setting the current rating at Neutral. For the third quarter, Tesla had an EPS of $1.86, compared to year-ago quarter EPS of $0.76. The current stock performance of Tesla shows a 52-week-high of $1243.49 and a 52-week-low of $539.49. Moreover, at the end of the last trading period, the closing price was at $932.57.

Goldman Sachs initiated coverage on RBC Bearings Inc ROLL with a Neutral rating. The price target for RBC Bearings is set to $217.00. RBC Bearings earned $0.89 in the second quarter, compared to $0.93 in the year-ago quarter. The current stock performance of RBC Bearings shows a 52-week-high of $250.52 and a 52-week-low of $160.51. Moreover, at the end of the last trading period, the closing price was at $200.31.

RBC Capital initiated coverage on Cannae Holdings Inc CNNE with an Outperform rating. The price target for Cannae Holdings is set to $42.00. For the third quarter, Cannae Holdings had an EPS of $1.36, compared to year-ago quarter EPS of $1.44. At the moment, the stock has a 52-week-high of $46.57 and a 52-week-low of $29.16. Cannae Holdings closed at $32.46 at the end of the last trading period.

HC Wainwright & Co. initiated coverage on ProPhase Labs Inc PRPH with a Buy rating. The price target for ProPhase Labs is set to $12.00. In the third quarter, ProPhase Labs showed an EPS of $0.26, compared to $0.05 from the year-ago quarter. The current stock performance of ProPhase Labs shows a 52-week-high of $16.04 and a 52-week-low of $4.41. Moreover, at the end of the last trading period, the closing price was at $7.29.

With a Buy rating, HC Wainwright & Co. initiated coverage on 89bio Inc ETNB. The price target seems to have been set at $46.00 for 89bio. In the third quarter, 89bio showed an EPS of $1.41, compared to $0.86 from the year-ago quarter. The stock has a 52-week-high of $28.28 and a 52-week-low of $10.93. At the end of the last trading period, 89bio closed at $11.48.

HC Wainwright & Co. initiated coverage on Ayala Pharmaceuticals Inc AYLA with a Buy rating. The price target for Ayala Pharmaceuticals is set to $18.00. For the third quarter, Ayala Pharmaceuticals had an EPS of $0.68, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $28.68 and a 52-week-low of $7.74. At the end of the last trading period, Ayala Pharmaceuticals closed at $9.03.

With an Outperform rating, SVB Leerink initiated coverage on Compass Therapeutics Inc CMPX. The price target seems to have been set at $12.00 for Compass Therapeutics. The current stock performance of Compass Therapeutics shows a 52-week-high of $7.00 and a 52-week-low of $2.01. Moreover, at the end of the last trading period, the closing price was at $3.05.

With a Buy rating, HC Wainwright & Co. initiated coverage on Franco-Nevada Corp FNV. The price target seems to have been set at $167.00 for Franco-Nevada. Franco-Nevada earned $0.87 in the third quarter, compared to $0.80 in the year-ago quarter. The current stock performance of Franco-Nevada shows a 52-week-high of $163.79 and a 52-week-low of $105.62. Moreover, at the end of the last trading period, the closing price was at $133.58.

With a Buy rating, HC Wainwright & Co. initiated coverage on Edesa Biotech Inc EDSA. The price target seems to have been set at $16.00 for Edesa Biotech. For the third quarter, Edesa Biotech had an EPS of $0.36, compared to year-ago quarter EPS of $0.20. The current stock performance of Edesa Biotech shows a 52-week-high of $12.00 and a 52-week-low of $4.05. Moreover, at the end of the last trading period, the closing price was at $5.71.

HC Wainwright & Co. initiated coverage on BioCardia Inc BCDA with a Buy rating. The price target for BioCardia is set to $9.00. For the third quarter, BioCardia had an EPS of $0.16, compared to year-ago quarter EPS of $0.30. The stock has a 52-week-high of $5.48 and a 52-week-low of $1.65. At the end of the last trading period, BioCardia closed at $1.75.

See all analyst ratings initiations.